Literature DB >> 14990724

Infectious salmon anemia virus specifically binds to and hydrolyzes 4-O-acetylated sialic acids.

Audny Hellebø1, Ulrike Vilas, Knut Falk, Reinhard Vlasak.   

Abstract

Infectious salmon anemia virus (ISAV) is the causative agent of infections in farmed Atlantic salmon. ISAV presumably represents a new genus within the Orthomyxoviridae. ISAV has been shown earlier to exhibit a receptor-destroying activity, which was defined as an acetylesterase with unknown specificity. We have analyzed the substrate specificity of the ISAV esterase in detail. Purified ISAV hydrolyzed free 5-N-acetyl-4-O-acetyl neuraminic acid. In addition, the purified 9-O-acetylated sialic acid derivative was also hydrolyzed, but at lower rates. When we used a glycosidically bound substrate, ISAV was unable to hydrolyze 9-O-acetylated sialic acid, which represents the major substrate for the influenza C virus esterase. ISAV completely de-O-acetylated glycoprotein-bound 5-N-acetyl-4-O-acetyl neuraminic acid. Thus, the enzymatic activity of the hemagglutinin-esterase of ISAV is comparable to that of the sialate-4-O-esterases of murine coronaviruses and related group 2 coronaviruses. In addition, we found that ISAV specifically binds to glycoproteins containing 4-O-acetylated sialic acids. Both the ISAV esterase and recombinant rat coronavirus esterase specific for 4-O-acetylated sialic acids hydrolyzed ISAV receptors on horse and rabbit erythrocytes, indicating that this sialic acid represents a receptor determinant for ISAV.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14990724      PMCID: PMC353765          DOI: 10.1128/jvi.78.6.3055-3062.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Initial events in infectious salmon anemia virus infection: evidence for the requirement of a low-pH step.

Authors:  T M Eliassen; M K Frøystad; B H Dannevig; M Jankowska; A Brech; K Falk; K Romøren; T Gjøen
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Hydrolysis of sialic acids and O-acetylated sialic acids with propionic acid.

Authors:  T P Mawhinney; D L Chance
Journal:  Anal Biochem       Date:  1994-11-15       Impact factor: 3.365

3.  Hemagglutinin-esterase, a novel structural protein of torovirus.

Authors:  L A Cornelissen; C M Wierda; F J van der Meer; A A Herrewegh; M C Horzinek; H F Egberink; R J de Groot
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

Review 4.  Toroviruses: replication, evolution and comparison with other members of the coronavirus-like superfamily.

Authors:  E J Snijder; M C Horzinek
Journal:  J Gen Virol       Date:  1993-11       Impact factor: 3.891

5.  A sialic acid analogue acting as a receptor determinant for binding but not for infection by influenza C virus.

Authors:  R Brossmer; R Isecke; G Herrler
Journal:  FEBS Lett       Date:  1993-05-24       Impact factor: 4.124

6.  Phylogenetic and evolutionary relationships among torovirus field variants: evidence for multiple intertypic recombination events.

Authors:  S L Smits; A Lavazza; K Matiz; M C Horzinek; M P Koopmans; R J de Groot
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

7.  The receptor-destroying enzyme of influenza C virus is required for entry into target cells.

Authors:  B Strobl; R Vlasak
Journal:  Virology       Date:  1993-02       Impact factor: 3.616

8.  Isolation of the causal virus of infectious salmon anaemia (ISA) in a long-term cell line from Atlantic salmon head kidney.

Authors:  B H Dannevig; K Falk; E Namork
Journal:  J Gen Virol       Date:  1995-06       Impact factor: 3.891

9.  Transfer of an esterase-resistant receptor analog to the surface of influenza C virions results in reduced infectivity due to aggregate formation.

Authors:  K Höfling; R Brossmer; H Klenk; G Herrler
Journal:  Virology       Date:  1996-04-01       Impact factor: 3.616

10.  Comparison of the genome organization of toro- and coronaviruses: evidence for two nonhomologous RNA recombination events during Berne virus evolution.

Authors:  E J Snijder; J A den Boon; M C Horzinek; W J Spaan
Journal:  Virology       Date:  1991-01       Impact factor: 3.616

View more
  45 in total

1.  Characterization of a carbohydrate epitope defined by the monoclonal antibody H185: sialic acid O-acetylation on epithelial cell-surface mucins.

Authors:  Pablo Argüeso; Mika Sumiyoshi
Journal:  Glycobiology       Date:  2006-08-29       Impact factor: 4.313

2.  Characterisation of a monoclonal antibody detecting Atlantic salmon endothelial and red blood cells, and its association with the infectious salmon anaemia virus cell receptor.

Authors:  Maria Aamelfot; Simon C Weli; Ole B Dale; Erling O Koppang; Knut Falk
Journal:  J Anat       Date:  2013-02-25       Impact factor: 2.610

3.  Expression of the infectious salmon anemia virus receptor on atlantic salmon endothelial cells correlates with the cell tropism of the virus.

Authors:  Maria Aamelfot; Ole Bendik Dale; Simon Chioma Weli; Erling Olaf Koppang; Knut Falk
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

4.  Bioinformatic analysis of the genome of infectious salmon anemia virus associated with outbreaks with high mortality in Chile.

Authors:  L Cottet; M Cortez-San Martin; M Tello; E Olivares; A Rivas-Aravena; E Vallejos; A M Sandino; E Spencer
Journal:  J Virol       Date:  2010-09-01       Impact factor: 5.103

5.  Inhibitory effect of a nucleotide analog on infectious salmon anemia virus infection.

Authors:  Andrea Rivas-Aravena; Eva Vallejos-Vidal; Marcelo Cortez-San Martin; Felipe Reyes-Lopez; Mario Tello; Patricia Mora; Ana María Sandino; Eugenio Spencer
Journal:  J Virol       Date:  2011-06-08       Impact factor: 5.103

Review 6.  Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.

Authors:  Susan R Weiss; Sonia Navas-Martin
Journal:  Microbiol Mol Biol Rev       Date:  2005-12       Impact factor: 11.056

7.  Chemical Synthesis and In Vitro Evaluation of a Phage Display-Derived Peptide Active against Infectious Salmon Anemia Virus.

Authors:  Nicolás Ojeda; Constanza Cárdenas; Fanny Guzmán; Sergio H Marshall
Journal:  Appl Environ Microbiol       Date:  2016-04-04       Impact factor: 4.792

8.  Development of a reverse genetic system for infectious salmon anemia virus: rescue of recombinant fluorescent virus by using salmon internal transcribed spacer region 1 as a novel promoter.

Authors:  Daniela Toro-Ascuy; Carolina Tambley; Carolina Beltran; Carolina Mascayano; Nicolas Sandoval; Eduardo Olivares; Rafael A Medina; Eugenio Spencer; Marcelo Cortez-San Martín
Journal:  Appl Environ Microbiol       Date:  2015-02       Impact factor: 4.792

9.  Coronavirus receptor switch explained from the stereochemistry of protein-carbohydrate interactions and a single mutation.

Authors:  Mark J G Bakkers; Qinghong Zeng; Louris J Feitsma; Ruben J G Hulswit; Zeshi Li; Aniek Westerbeke; Frank J M van Kuppeveld; Geert-Jan Boons; Martijn A Langereis; Eric G Huizinga; Raoul J de Groot
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-16       Impact factor: 11.205

10.  Identification and characterization of viral structural proteins of infectious salmon anemia virus.

Authors:  Knut Falk; Vidar Aspehaug; Reinhard Vlasak; Curt Endresen
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.